BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in human gastric juice. It is widely researched for its regenerative, anti-inflammatory, and tissue-healing properties in animal studies and anecdotal human use. It is not approved by the FDA for human therapeutic use and remains a research chemical in most countries bpc dosage

Common Forms of BPC-157

• Oral capsules/tablets – enteric-coated for gastric stability
• Subcutaneous (SubQ) injection – most common in research and self-experimentation
• Intramuscular (IM) injection – sometimes used near injury site
• Nasal spray – emerging but less studied
• Topical creams – rare and poorly absorbed

General Dosage Ranges Reported in Literature and User Reports

Subcutaneous or IM Injection (Most Common)

• Standard healing dose: 250–500 mcg per day
• Most frequently reported single dose: 250 mcg twice daily (total 500 mcg/day)
• Higher-end doses: 700–1,000 mcg/day (usually split 2–3 times)
• Micro-dosing approach: 100–200 mcg/day for maintenance or mild issues
• Loading phase (first 1–2 weeks): some users go up to 750–1,000 mcg/day, then drop to 250–500 mcg

Oral Administration

• Typically 2–4× higher than injection due to first-pass degradation
• Common oral dose: 500–1,000 mcg per day (often 500 mcg twice daily)
• Some brands claim bioavailability is comparable to injection when enteric-coated, but evidence is limited.

Per-Injury-Site Injection (Near Tendon, Joint, etc.)

• 250–500 mcg injected as close as comfortably possible to the injury, 1–2× daily

Typical Cycle Length

• Acute injuries: 2–6 weeks
• Chronic conditions or gut healing: 4–12 weeks
• Maintenance (rare): 100–250 mcg a few times per week Most users stop or drastically reduce dosage once desired healing is achieved.

Administration Tips

• Use insulin syringes (0.3–1 mL, 29–31G) for SubQ/IM
• Reconstitute lyophilized BPC-157 with bacteriostatic water
• Store reconstituted peptide in refrigerator (2–8°C) for up to 4–6 weeks
• Inject on empty or semi-empty stomach for potentially better absorption (anecdotal)

Reported Side Effects at Common Dosages

At 250–1,000 mcg/day most people report:

• Virtually no side effects
• Occasional mild injection-site redness
• Rare headaches or warmth/flushing (usually transient)

Doses above 1–2 mg/day have occasionally been linked to nausea, dizziness, or blood-pressure changes in anecdotal reports.

Important Legal & Safety Notes

• BPC-157 is banned by WADA and most sports governing bodies
• It is sold strictly “for research purposes only” in most countries
• Long-term human safety data do not exist
• Always verify third-party testing (COA) for purity when sourcing

Sample Beginner Protocol (Most Common)

• 250 mcg SubQ twice daily (morning and evening)
• Total: 500 mcg/day
• Duration: 4–6 weeks
• Optional: taper down to 250 mcg once daily for last week

Always consult a knowledgeable healthcare professional before experimenting with research peptides. This article is for informational purposes only and does not constitute medical advice.